Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13670888 | 1.00 | KDM4E (0.40) | KDM4EATML3MBTL1SIGMAR1 | |
| SCHEMBL4403023 | 0.98 | KDM4E (0.38) | KDM4EATML3MBTL1 | |
| SCHEMBL19071306 | 0.97 | KDM4E (0.38) | KDM4EATML3MBTL1 | |
| SCHEMBL14051424 | 0.95 | KDM4E (0.38) | KDM4EATML3MBTL1 | |
| SCHEMBL8956236 | 0.95 | KDM4E (0.38) | KDM4EATML3MBTL1 | |
| SCHEMBL24611529 | 0.95 | KDM4E (0.38) | KDM4EATML3MBTL1 | |
| SCHEMBL8956232 | 0.94 | KDM4E (0.37) | KDM4EATML3MBTL1 | |
| SCHEMBL8950338 | 0.94 | KDM4E (0.37) | KDM4EATML3MBTL1 | |
| SCHEMBL8950345 | 0.94 | KDM4E (0.37) | KDM4EATML3MBTL1 | |
| SCHEMBL8956229 | 0.94 | KDM4E (0.37) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090252990-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-10-08 | — | — | US | disclosed |
| US-20090179555-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-07-16 | — | — | US | disclosed |
| US-20090153037-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090252990-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | AOX1, LEF1, ODC1 | KDM4E 2236/4885ATM 4630/4885L3MBTL1 2979/4885 |
| US-20090153037-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | NDUFS2, ALDH1A2, ODC1 | KDM4E 1792/4885ATM 4681/4885L3MBTL1 3164/4885 |
| US-20090179555-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | NDUFS2, ALDH1A2, ODC1 | KDM4E 1792/4885ATM 4681/4885L3MBTL1 3164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.